Form 4: Medpace Holdings Director Acquires Stock Options
SEC Form 4 Filing
Director Femida H. Gwadry-Sridhar acquired stock options in Medpace Holdings, Inc. on May 17, 2024.
Summary
- On May 17, 2024, Femida H. Gwadry-Sridhar, a director of Medpace Holdings, Inc., acquired 953 stock options.
- The exercise price of these options is $393.3.
- The options vest on the earlier of the day before the next annual meeting or the first anniversary of the grant date, contingent upon continued service on the board.
- The options expire on May 17, 2031.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. The acquisition of stock options by a director is generally viewed as a slightly positive sign, but the document itself is factual and doesn't convey strong sentiment.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the transactions of company directors and officers.
Key Dates
| Date | Description |
|---|---|
| 05/17/2024 | Date of transaction: Director acquired stock options. |
| 05/17/2031 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.